loadpatents
Patent applications and USPTO patent grants for Deininger; David D..The latest application filed is for "isotopically enriched azaindoles".
Patent | Date |
---|---|
Isotopically Enriched Azaindoles App 20160168147 - Brummel; Christopher Lee ;   et al. | 2016-06-16 |
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20140031277 - Cottrell; Kevin M. ;   et al. | 2014-01-30 |
Gyrase inhibitors and uses thereof Grant 8,404,852 - Charifson , et al. March 26, 2 | 2013-03-26 |
Gyrase Inhibitors And Uses Thereof App 20130023525 - Charifson; Paul S. ;   et al. | 2013-01-24 |
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease App 20130012430 - Tung; Roger D. ;   et al. | 2013-01-10 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Grant 8,314,141 - Tung , et al. November 20, 2 | 2012-11-20 |
c-MET protein kinase inhibitors Grant 8,232,406 - Lauffer , et al. July 31, 2 | 2012-07-31 |
C-met Protein Kinase Inhibitors App 20110059936 - Lauffer; David J. ;   et al. | 2011-03-10 |
c-MET protein kinase inhibitors Grant 7,872,031 - Lauffer , et al. January 18, 2 | 2011-01-18 |
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20100330109 - Cottrell; Kevin M. ;   et al. | 2010-12-30 |
Inhibitors Of C-met And Uses Thereof App 20100190774 - Lauffer; David J. ;   et al. | 2010-07-29 |
Gyrase inhibitors and uses thereof Grant 7,727,992 - Charifson , et al. June 1, 2 | 2010-06-01 |
Inhibitors of c-Met and uses thereof Grant 7,728,017 - Lauffer , et al. June 1, 2 | 2010-06-01 |
Gyrase Inhibitors And Uses Thereof App 20100105701 - Charifson; Paul S. ;   et al. | 2010-04-29 |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,683,033 - Cottrell , et al. March 23, 2 | 2010-03-23 |
Gyrase inhibitors and uses thereof Grant 7,582,641 - Charifson , et al. September 1, 2 | 2009-09-01 |
Gyrase inhibitors and uses thereof Grant 7,569,591 - Charifson , et al. August 4, 2 | 2009-08-04 |
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease App 20090143312 - Tung; Roger D. ;   et al. | 2009-06-04 |
Gyrase inhibitors and uses thereof Grant 7,495,014 - Charifson , et al. February 24, 2 | 2009-02-24 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Grant 7,388,017 - Tung , et al. June 17, 2 | 2008-06-17 |
C-MET protein kinase inhibitors App 20070254868 - Lauffer; David J. ;   et al. | 2007-11-01 |
Inhibitors of c-Met and uses thereof App 20070191369 - Lauffer; David J. ;   et al. | 2007-08-16 |
Gyrase inhibitors and uses thereof App 20050256136 - Charifson, Paul S. ;   et al. | 2005-11-17 |
Gyrase inhibitors and uses thereof App 20050038247 - Charifson, Paul S. ;   et al. | 2005-02-17 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease App 20040266731 - Tung, Roger D. ;   et al. | 2004-12-30 |
Gyrase inhibitors and uses thereof App 20040235886 - Charifson, Paul S. ;   et al. | 2004-11-25 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Grant 6,617,309 - Tung , et al. September 9, 2 | 2003-09-09 |
Inhibitors of bace App 20030095958 - Bhisetti, Govinda R. ;   et al. | 2003-05-22 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease App 20020032175 - Tung, Roger D. ;   et al. | 2002-03-14 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease Grant 6,265,380 - Tung , et al. July 24, 2 | 2001-07-24 |
Aspartyl protease inhibitors Grant 5,945,413 - Tung , et al. August 31, 1 | 1999-08-31 |
Aspartyl protease inhibitors Grant 5,883,252 - Tung , et al. March 16, 1 | 1999-03-16 |
Renin inhibitors Grant 5,095,119 - Ocain , et al. March 10, 1 | 1992-03-10 |
Pyrrolimidazolones useful as renin inhibitors Grant 5,075,451 - Ocain , et al. December 24, 1 | 1991-12-24 |
Renin inhibitors Grant 5,064,965 - Ocain , et al. November 12, 1 | 1991-11-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.